SMR - Experimental and in silico approaches to target selection and tractability for drug discovery

Overview

A one day symposium jointly organised by the Society for Medicines Research (SMR) and the Fine Chemicals Group of the Society for Chemical Industries (SCI) on 21 March 2022 at the Francis Crick Institute, London, UK

The meeting will have two main themes:

1. Sources of target hypotheses for drug discovery
   and
2. Practicalities of early assessment of target intervention opportunities

Speakers will include:

• Lyn Jones (Dana-Farber Cancer Institute, Boston, USA)
• Jessica Eley (GSK Stevenage, UK)
• Victor Neduva (MSD, London, UK)
• Deb Rothman, (Merck, USA)
• Sarah Teichmann (University of Cambridge, UK)
• Andrew Leach (EBI, Cambridge, UK)
• Ian Storer (AstraZeneca, Cambridge, UK)
• Paul Brennan (University of Oxford, UK)